p38 MAP kinase: a convergence point in cancer therapy
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (3) , 125-129
- https://doi.org/10.1016/j.molmed.2004.01.007
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathwayOncogene, 2003
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- p38 Mitogen-Activated Protein Kinase Regulates Bax Translocation in Cyanide-Induced ApoptosisToxicological Sciences, 2003
- Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinomaCancer, 2003
- p38 Mitogen-Activated Protein Kinase Mediates Cell Death and p21-Activated Kinase Mediates Cell Survival during Chemotherapeutic Drug-induced Mitotic ArrestMolecular Biology of the Cell, 2003
- p38 Mitogen-Activated Protein Kinases on the Body Surface – A Function for p38δJournal of Investigative Dermatology, 2003
- p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeabilityThe FASEB Journal, 2002
- Down-regulation of the Phosphatidylinositol 3-Kinase/Akt Pathway Is Involved in Retinoic Acid-induced Phosphorylation, Degradation, and Transcriptional Activity of Retinoic Acid Receptor γ2Journal of Biological Chemistry, 2002
- Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammationNature, 1997
- Primary Structure of BMK1: A New Mammalian MAP KinaseBiochemical and Biophysical Research Communications, 1995